Area of research
Pulmonary and Respiratory Medicine · Rheumatology
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Urologic and reproductive health conditions, and Urinary Bladder and Prostate Research.
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies
Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer
A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy
Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer
Association Between Combined <i>TMPRSS2:ERG</i> and <i>PCA3</i> RNA Urinary Testing and Detection of Aggressive Prostate Cancer
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
Prediction of pathological stage based on clinical stage, serum prostate‐specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era
Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer
<sup>18</sup>F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies
High Prevalence of Screen Detected Prostate Cancer in West Africans: Implications for Racial Disparity of Prostate Cancer
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
UCL Discovery (University College London) 2014cited by 0position: middle
Multiple Intermediate-Risk Factors as a Prognostic Tool for Men With Localized Prostate Cancer
Prognostic <scp>G</scp> leason grade grouping: data based on the modified <scp>G</scp> leason scoring system
African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?
Germline Mutations in <i>HOXB13</i> and Prostate-Cancer Risk
An updated prostate cancer staging nomogram ( <scp>P</scp> artin tables) based on cases from 2006 to 2011
Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer?
Association of [−2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer
Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay
Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration